Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	9834
Country	Italy

Received	2014-03-01 15:39
Peer-Review Started	2014-03-02 18:24
To Make the First Decision	2014-04-15 15:20
Return for Revision	2014-04-16 18:31
Revised	2014-05-15 00:23
Second Decision	2014-09-10 13:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-09-10 13:48
Articles in Press	2014-09-10 13:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-10-31 12:16
Publish the Manuscript Online	2014-11-13 17:10

ISSN	2218-6220 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Minireviews
Article Title	Gynecological malignancies and hormonal therapies: Clinical management and recommendations
Manuscript Source	Invited Manuscript
All Author List	Anna Myriam Perrone, Federica Pozzati, Donatella Santini, Martina Rossi, Martina Procaccini, Lucia Casalini, Erica Santi, Marco Tesei, Claudio Zamagni and Pierandrea De Iaco
Funding Agency and Grant Number
Corresponding Author	Anna Myriam Perrone, PhD, SSD, Oncologic Gynecology Unit, Sant’Orsola-Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy. amperrone@libero.it
Key Words	Iatrogenic menopause; Gynecological cancer; Hormone replacement therapy; Risk of recurrence; Climateric symptoms; Cardiovascular benefits; Clinical practice
Core Tip	In this paper we analyze the role of hormone replacement therapy (HRT) in patients affected by gynecological neoplasms with iatrogenic menopause symptoms. We have analysed more than 70 articles with the aim to evaluate the possibility of using HRT in different gynaecological malignancies related to stage and grade of the neoplasm. The literature shows that the use of HRT is controversial in type?Ⅰ?of endometrial cancer, endometrioid type of ovarian cancer, uterine cervix adenocarcinoma and endometrial stroma and leiomyosarcoma.
Publish Date	2014-11-13 17:10
Citation	Perrone AM, Pozzati F, Santini D, Rossi M, Procaccini M, Casalini L, Santi E, Tesei M, Zamagni C, De Iaco P. Gynecological malignancies and hormonal therapies: Clinical management and recommendations. World J Obstet Gynecol 2014; 3(4): 162-170
URL	http://www.wjgnet.com/2218-6220/full/v3/i4/162.htm
DOI	http://dx.doi.org/10.5317/wjog.v3.i4.162

Full Article (PDF)	WJOG-3-162.pdf
Full Article (Word)	WJOG-3-162.doc
Manuscript File	9834-Review.docx
Answering Reviewers	9834-Answering reviewers.pdf
Copyright License Agreement	9834-Copyright assignment.pdf
Peer-review Report	9834-Peer review(s).pdf
Scientific Misconduct Check	9834-CrossCheck.jpg
Scientific Editor Work List	9834-Scientific editor work list.pdf